# S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

> **NCT00005597** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 25 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumor

## Interventions

- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00005597
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005597, "S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*